Reported 2 days ago
Zoetis Inc. (NYSE:ZTS) is highlighted among the top pharma dividend stocks for 2025, recognized for its leading role in the animal health sector and a strong track record of innovation. With a reported revenue of $2.22 billion in Q1 2025, surpassing estimates, and a solid dividend history of 14 consecutive years of increases, the company is well-positioned for future growth, especially with recent product launches enhancing sales. Despite its appeal, some analysts suggest that certain AI stocks may present better investment opportunities.
Source: YAHOO